rac-N-(3,5-Dichlorophenyl)-4-[4-(propan-2-yl)phenyl]-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxamide

ID: ALA4524393

PubChem CID: 155520123

Max Phase: Preclinical

Molecular Formula: C23H22Cl2N2OS

Molecular Weight: 445.42

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  CC(C)c1ccc(C2c3ccsc3CCN2C(=O)Nc2cc(Cl)cc(Cl)c2)cc1

Standard InChI:  InChI=1S/C23H22Cl2N2OS/c1-14(2)15-3-5-16(6-4-15)22-20-8-10-29-21(20)7-9-27(22)23(28)26-19-12-17(24)11-18(25)13-19/h3-6,8,10-14,22H,7,9H2,1-2H3,(H,26,28)

Standard InChI Key:  QVCVYPTWFIJYFA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   15.9962  -27.0556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7082  -26.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7082  -25.8221    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9962  -25.4055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9966  -24.5813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7127  -24.1694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7131  -23.3451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9980  -22.9317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2812  -23.3487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2843  -24.1716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2841  -26.6472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2841  -25.8176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4951  -25.5611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0074  -26.2323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4951  -26.9034    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.4239  -25.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1372  -25.8264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.4263  -24.5867    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8529  -25.4160    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5630  -25.8341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2782  -25.4244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2811  -24.5985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5628  -24.1840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8505  -24.5962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9913  -25.8394    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.5623  -23.3590    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.9969  -22.1067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7109  -21.6932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2819  -21.6952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
  3 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 23 26  1  0
  8 27  1  0
 27 28  1  0
 27 29  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4524393

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 445.42

Molecular Weight (Monoisotopic): 444.0830

AlogP: 7.36

#Rotatable Bonds: 3

Polar Surface Area: 32.34

Molecular Species: NEUTRAL

HBA: 2

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 3

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.74

CX Basic pKa: ┄

CX LogP: 7.24

CX LogD: 7.24

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.45

Np Likeness Score: -1.78

References

1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G..  (2019)  Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.,  62  (22): [PMID:31670515] [10.1021/acs.jmedchem.9b01382]

Source

Source(1):

• Scientific Literature